Like all pharmaceutical companies in the UK, Pfizer operates within a series of regulations, which set the standards for advertising and promotion of prescription-only medicines.
As a member of the Association of British Pharmaceutical Industry (ABPI), Pfizer adheres to the ABPI Code of Practice.
Pfizer supports the Code, and devotes considerable resources to ensure compliance.
These standards moderate the kind of information about prescription-only medicines we can offer on this website, as well as in all other forms of communication.
This Code of Practice aims to ensure that pharmaceutical companies operate in a responsible, ethical and professional manner. It defines what information pharmaceutical companies can provide to healthcare professionals, who may prescribe its medicines to patients, and what information they can offer to members of the public - in advertisements, press announcements, or on websites such as this one.
The ABPI Code is administered by the Prescription Medicines Code of Practice Authority (PMCPA).
The Code of Practice has been regularly revised since its inception in 1958 and is drawn up in consultation with the British Medical Association (BMA), the Royal Pharmaceutical Society (RPS), the Royal College of Nursing (RCN) and the Medicines and Healthcare products Regulatory Agency (MHRA).
You can find out more about the ABPI and PMCPA by following the links in the 'Related viewing' on the right side of this page.